Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs

OBJECTIVE: Antiproliferative activity of somatostatin analogs (SSAs) has been demonstrated in digestive neuroendocrine tumors (NETs), but few data have been published in patients with pulmonary NETs. We therefore conducted a retrospective study to provide additional data on the outcome of patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenotti, Elisa, Alberti, Andrea, Spada, Francesca, Amoroso, Vito, Maisonneuve, Patrick, Grisanti, Salvatore, Baggi, Alice, Bianchi, Susanna, Fazio, Nicola, Berruti, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111295/
https://www.ncbi.nlm.nih.gov/pubmed/33986731
http://dx.doi.org/10.3389/fendo.2021.669484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111295/
https://www.ncbi.nlm.nih.gov/pubmed/33986731
http://dx.doi.org/10.3389/fendo.2021.669484

Ejemplares similares